Ethiopia is taking significant steps to combat cervical cancer, a disease that claims the lives of more than 5,000 people annually in the country. In a bid to reduce these alarming statistics, the Ministry of Health (MoH) has announced the launch of a comprehensive HPV vaccination program, marking a pivotal milestone in the fight against cervical cancer.
Mekeds Daba Minister of Health stated, “Ethiopia is losing more than 5,000 people to cervical cancer every year,” emphasizing the urgent need for preventive measures. The human papillomavirus (HPV) is recognized as the leading cause of cervical cancer and other related diseases, making its elimination a critical objective for public health in Ethiopia, especially given the heightened risk among women living with HIV.
Data indicates that women with HIV are six times more likely to develop cervical cancer, primarily due to HPV. This situation is particularly concerning as 90% of new cervical cancer cases and deaths worldwide occur in low- and middle-income countries.
The national vaccination campaign was officially launched at Tulu Dimtu No. 1 Primary School in Sheger City, Oromia Region. Dr. Netstanet Workneh, Head of the Oromia Health Office, announced that over 3.2 million girls in the Oromia region alone will be vaccinated as part of this year’s initiative.
Emily Kobayashi, head of the HPV vaccines program at GAVI, highlighted the importance of this vaccination effort for women’s health in Ethiopia. “The provision of the cervical cancer vaccine will ensure women’s health and safety,” she stated, noting that the vaccine can prevent up to 90% of cervical cancer cases.
The vaccination campaign will run from November 9 to 13 and aims to immunize over 7.5 million girls aged 9 to 14 across schools, health facilities, and public gatherings throughout Ethiopia.
